IN2014DN09791A - - Google Patents
Info
- Publication number
- IN2014DN09791A IN2014DN09791A IN9791DEN2014A IN2014DN09791A IN 2014DN09791 A IN2014DN09791 A IN 2014DN09791A IN 9791DEN2014 A IN9791DEN2014 A IN 9791DEN2014A IN 2014DN09791 A IN2014DN09791 A IN 2014DN09791A
- Authority
- IN
- India
- Prior art keywords
- conjugates
- disclosed
- meningococcal
- immunogenic
- against meningococcal
- Prior art date
Links
- 150000004676 glycans Chemical class 0.000 abstract 3
- 229920001282 polysaccharide Polymers 0.000 abstract 3
- 239000005017 polysaccharide Substances 0.000 abstract 3
- 101710186862 Factor H binding protein Proteins 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651382P | 2012-05-24 | 2012-05-24 | |
| PCT/US2013/042428 WO2013177397A1 (en) | 2012-05-24 | 2013-05-23 | Multivalent meningococcal conjugates and methods for preparing cojugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09791A true IN2014DN09791A (cg-RX-API-DMAC10.html) | 2015-07-31 |
Family
ID=48579502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9791DEN2014 IN2014DN09791A (cg-RX-API-DMAC10.html) | 2012-05-24 | 2014-11-19 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US9427476B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN104428008B (cg-RX-API-DMAC10.html) |
| IN (1) | IN2014DN09791A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013177397A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ545647A (en) | 1999-05-19 | 2008-02-29 | Chiron Srl | Combination neisserial compositions |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| BRPI0907843A2 (pt) | 2008-02-21 | 2015-08-04 | Novartis Ag | Polipeptídeos de fhbp menigocócicos |
| RU2557315C2 (ru) | 2009-03-24 | 2015-07-20 | Новартис Аг | Адъювантный менингококковый белок, связывающий фактор н |
| US9427476B2 (en) * | 2012-05-24 | 2016-08-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multivalent meningococcal conjugates and methods for preparing conjugates |
| BR112014031386A2 (pt) * | 2012-06-14 | 2017-08-01 | Pasteur Institut | vacinas para meningococos do sorogrupo x |
| HRP20240433T1 (hr) | 2016-09-02 | 2024-07-05 | Sanofi Pasteur, Inc. | Cjepivo protiv neisseria meningitidis |
| CN108144056A (zh) * | 2016-12-02 | 2018-06-12 | 武汉博沃生物科技有限公司 | 多价肺炎球菌多糖结合疫苗及其制备方法 |
| CN107151270B (zh) * | 2017-03-22 | 2018-07-31 | 武汉博沃生物科技有限公司 | 重组ΔfHbp-NadA融合蛋白载体及其制备方法和应用 |
| GB202016604D0 (en) * | 2020-10-20 | 2020-12-02 | Univ Of Oxford | Compositions and methods for inducing an immune response |
| CN117643624A (zh) * | 2024-01-30 | 2024-03-05 | 成都康华生物制品股份有限公司 | 一种双价多糖结合疫苗的制备方法及双价多糖结合疫苗 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2194761C (en) | 1994-07-15 | 2006-12-19 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| JP2001513776A (ja) | 1997-02-28 | 2001-09-04 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | ＬＰＳ関連障害の処置における非メチル化ＣｐＧジヌクレオチドを含む核酸の使用 |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| ATE370740T1 (de) | 1997-05-20 | 2007-09-15 | Ottawa Health Research Inst | Verfahren zur herstellung von nukleinsäurekonstrukten |
| ATE356630T1 (de) | 1998-04-03 | 2007-04-15 | Univ Iowa Res Found | Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine |
| EP1266223B1 (en) | 2000-03-20 | 2007-05-16 | Massachusetts Institute of Technology | Inorganic particle conjugates |
| GB0220197D0 (en) | 2002-08-30 | 2002-10-09 | Univ Utrecht | Refolding method |
| US9173931B2 (en) | 2003-08-06 | 2015-11-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Process for preparing polysaccharide-protein conjugate vaccines |
| US8048432B2 (en) | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| KR20150038626A (ko) * | 2006-03-17 | 2015-04-08 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
| BRPI0907843A2 (pt) | 2008-02-21 | 2015-08-04 | Novartis Ag | Polipeptídeos de fhbp menigocócicos |
| AU2010227221B2 (en) | 2009-03-24 | 2015-01-22 | Novartis Ag | Combinations including pneumococcal serotype 14 saccharide |
| NZ595291A (en) | 2009-03-24 | 2013-08-30 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| EP2538969A4 (en) | 2010-02-22 | 2013-11-27 | Liquidia Technologies Inc | VACCINES FROM POLYSACCHARIDE PARTICLES |
| CN102869377A (zh) * | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| US9427476B2 (en) * | 2012-05-24 | 2016-08-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multivalent meningococcal conjugates and methods for preparing conjugates |
-
2013
- 2013-05-23 US US14/402,988 patent/US9427476B2/en active Active
- 2013-05-23 WO PCT/US2013/042428 patent/WO2013177397A1/en not_active Ceased
- 2013-05-23 CN CN201380037403.7A patent/CN104428008B/zh active Active
-
2014
- 2014-11-19 IN IN9791DEN2014 patent/IN2014DN09791A/en unknown
-
2016
- 2016-08-01 US US15/225,102 patent/US9956278B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160331824A1 (en) | 2016-11-17 |
| CN104428008A (zh) | 2015-03-18 |
| US9427476B2 (en) | 2016-08-30 |
| US9956278B2 (en) | 2018-05-01 |
| WO2013177397A1 (en) | 2013-11-28 |
| CN104428008B (zh) | 2020-10-09 |
| US20150110829A1 (en) | 2015-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN09791A (cg-RX-API-DMAC10.html) | ||
| PH12018501517A1 (en) | Neisseria meningitidis compositions and methods thereof | |
| EP4286000A3 (en) | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | |
| BR112012007876A2 (pt) | "membranas de troca de íons" | |
| MX2013013111A (es) | Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma. | |
| MY169837A (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| MY167579A (en) | Glycoconjugation processes and compositions | |
| IN2014DN08830A (cg-RX-API-DMAC10.html) | ||
| WO2015110940A3 (en) | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | |
| GB201101665D0 (en) | Immunogenic compositions | |
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| MX2019001761A (es) | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis. | |
| MX2015002482A (es) | Composicion inmunogenica. | |
| AU2013331781A8 (en) | Immunogenic composition comprising 1 or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae. | |
| MX357538B (es) | Vacunas para meningococo de serogrupo x. | |
| MY199399A (en) | Novel polysaccharide-protein conjugates and process to obtain thereof | |
| BR112012007877A2 (pt) | meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis | |
| WO2012103444A3 (en) | Immunogenic compositions and reagents for preparing | |
| HK1224187A1 (zh) | 针对药物成瘾的疫苗组合物 | |
| HK1211795A1 (en) | Synthetic oligosaccharides for p. aeruginosa vaccine | |
| MX2013002841A (es) | Composiciones inmunogenas. |